Stocks · News reference
Connect Biopharma Expects Topline Results From Phase 2 Seabreeze STAT Studies In September 2026
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Connect Biopharma Holdings Ltd (CNTB)
Filed: 2026-08-12 AccNo: 0001835268-26-000027 Size: 234 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Oppenheimer Initiates Coverage On Connect Biopharma Hldgs with Outperform Rating, Announces Price Target of $8